Su Zeng
- Cancer Research top 10%
- MicroRNA in disease regulation 5
-
- Advanced biosensing and bioanalysis techniques 13
- RNA Interference and Gene Delivery 9
- DNA and Nucleic Acid Chemistry 5
- Molecular Biology Techniques and Applications 2
- Pharmaceutical Science top 10%
- Biomaterials top 10%
-
- Molecular Sensors and Ion Detection 2
-
- Pharmacogenetics and Drug Metabolism 2
- Berberine and alkaloids research 1
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Su Zeng
20 papers receiving 715 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 219
- Molecular Biology 550
- Pharmaceutical Science 45
- Biomaterials 95
- Surfaces, Coatings and Films 24
Countries citing papers authored by Su Zeng
This map shows the geographic impact of Su Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Zeng more than expected).
Fields of papers citing papers by Su Zeng
This network shows the impact of papers produced by Su Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Zeng. The network helps show where Su Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Su Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 11 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 35 | |
| 10 | 2019 | 37 | |
| 11 | Research advances in the detection of miRNAbreakdown → | 2019 | 320 |
| 12 | 2019 | 10 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 5 | |
| 15 | 2014 | 22 | |
| 16 | 2010 | 24 | |
| 17 | 2010 | 17 | |
| 18 | Expression of CYP3A23/1, CYP3A2, PXR, CAR and HNF4alpha in large-for-gestational-age neonatal rats. | 2009 | 5 |
| 19 | 2006 | 14 | |
| 20 | 2006 | 172 |
About Su Zeng
Su Zeng is a scholar working on Cancer Research, Molecular Biology and Spectroscopy, having authored 22 papers that have together received 726 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (13 papers), RNA Interference and Gene Delivery (9 papers), MicroRNA in disease regulation (5 papers), DNA and Nucleic Acid Chemistry (5 papers), Molecular Sensors and Ion Detection (2 papers), Molecular Biology Techniques and Applications (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Cancer Research (219 citations), Molecular Biology (550 citations) and Pharmaceutical Science (45 citations). Su Zeng has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Sheng Cai, Jiawei Ye, Mingcheng Xu, Jian You, Hong Yuan, Yongzhong Du, Mengdan Zhao, Fuqiang Hu, Haihong Hu and Abdu Ahmed Abdullah AL‐maskri.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.